Epigenetics Market Is Set To Garner Staggering Revenues By 2022

The global epigenetics market is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.

Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.

Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.

Technology advancements in the field of epigenetics especially pertaining to the detection of methylation markers related to cancer development is expected to improve usage rates during the forecast period. For instance, Epi proLung BL Reflex Assay by Epigenomics helps in the diagnosis of lung cancer by determining methylation of SHOX2 biomarker gene.

Browse full research report on Epigenetics Market: www.grandviewresearch.com/industry-analysis/epigenetics-market            

Further key findings from the study suggest:                                     

  • Epigenetic reagents was the largest market valued at over USD 1.2 billion in 2014 owing to the increasing amount of R&D investments and high consumption rates. Kits are expected to gain rapid growth in demand due to the increasing need of rapid and accurate detection techniques.
  • DNA methylation was the largest technology segment accounting for over 47.0% revenue in 2014. The introduction of technological advancement such as Methylation Sensitive PCR (MSP) and rapid adoption of these products to improve diagnostics efficiency are some factors attributing for its largest share.
  • Oncology was the largest application market, with revenue valued at over USD 2.75 billion. Growing prevalence of cancer with epigenetic modification base and strong product pipeline are some factors attributing to its market position.
  • Non oncology segment is anticipated to register the fastest growth of over 20.0% during the forecast period. The segment is dominated by metabolic diseases owing to, the growing base of population suffering from diabetes and organ failure and increasing prevalence of sedentary lifestyle.
  • North America was observed to be the largest regional epigenetics market accounting for over 38.0% of the overall revenue, due to factors such as the increasing cancer prevalence, increasing amount of funding for R&D, growing collaborations between large pharmaceutical firms for development of improved therapeutics, high patient awareness levels.
  • The Asia Pacific market is estimated to witness lucrative growth over the forecast period owing to, the presence of large prevalence of target diseases and high unmet medical needs
  • Some key players of the epigenetics market include Illumina, Abcam, Diagenode, Thermo Fisher Scientific, Merck, Zymo research, Qiagen, CellCentric Ltd, Chroma Therapeutics Ltd, Eisai Co. Ltd, Novartis International AG, Oncolys Biopharma Inc., Syndax Pharmaceuticals, Inc., Valirx Plc and Sigma-Aldrich Corporation.
  • Extensive R&D initiatives aimed at the development of novel drugs and the presence of strong product pipeline is expected to further boost market growth over the forecast period.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                                                                                                                                                                                                            

Grand View Research has segmented the global epigenetics market on the basis of product, technology, application and region:

Epigenetics Product Outlook (Revenue, USD Million, 2015 – 2022)

  • Reagents
  • Kits
  • Instruments
  • Enzymes
  • Services

Epigenetics Technology Outlook (Revenue, USD Million, 2015 – 2022)

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large noncoding RNA
  • MicroRNA Modification
  • Chromatin structures

Epigenetics Application Outlook (Revenue, USD Million, 2015 – 2022)

  • Oncology
    • Solid Tumors
    • Liquid Tumors
  • Non Oncology
    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases

Epigenetics Market  Regional Outlook(Revenue, USD Million, 2015 – 2022)

    • North America
      • U.S.
      • Canada
    • Europe
      • UK
      • Germany
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Brazil
      • Mexico
    • Middle East and Africa (MEA)
      • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-epigenetics-market                                                                                                                                                                            

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Advertisements

Surgical Microscopes Market Will Be Worth $385.2 Million By 2025: Grand View Research, Inc.

The U.S. surgical microscopes market size is expected to reach USD 385.2 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 10.7% during the forecast period. Increasing prevalence of chronic disorders such as cancer and cardiovascular diseases, which require surgical intervention, is anticipated to bolster the growth of the operating microscopes market over the forecast period.

According to the Center for Disease Control and Prevention (CDC) in 2014, the cancer prevalence rate in the U.S. was in the range of 380.4-510.7 incidents per 100,000 people. States with the highest cancer incidence rates were Kentucky, Delaware, Pennsylvania, Maine, New Hampshire, Louisiana, Connecticut, New York, Iowa, and Michigan. These states are estimated to have greater demand for the product due to the requirement of more frequent surgical interventions.

us-surgical-microscope-market

Awareness regarding advantages of minimally invasive surgeries is also expected to stoke the growth of the market. Surgical microscope is one of the key devices needed for minimally invasive surgeries. Advantages of minimally invasive surgeries include reduced overall healthcare cost, reduced recovery time, and lesser chances of hospital acquired infections. Thus, demand for operating microscopes is estimated to increase over the forecast period as penetration of minimally invasive surgeries across all medical fields is on a rise.

Browse full research report on Surgical Microscopes Market: www.grandviewresearch.com/industry-analysis/us-surgical-microscopes-market

Further key findings from the study suggest:                     

  • In terms of revenue, on caster was the leading type segment in the market in 2016 and is anticipated to hold large share throughout the forecast period, exhibiting a CAGR of 11.5% over the forecast period
  • On the basis of application, oncology is likely to account for the largest share in terms of revenue, while the neurosurgery and spine surgery segments are estimated to register the highest CAGR over the forecast period
  • Based on end-use, hospitals were the leading revenue contributors in 2016. The trend is estimated to continue throughout the forecast period.
  • Key players operating in the U.S. surgical microscopes market include Seiler Precision Microscopes; Alcon Laboratories; Alltion (Wuzhou) Co. Ltd.; Carl Zeiss; Leica Microsystems; Takagi Seiko Co Ltd.; and Topcon Corporation Inc.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                        

Grand View Research has segmented the U.S. surgical microscopes market report on the basis of type, application, end-use, and region:

U.S. Surgical Microscopes Type Outlook (Revenue, USD Million, 2012 – 2025)

  • On Casters
  • Wall Mounted
  • Table Top
  • Ceiling Mounted

U.S. Surgical Microscopes Application Outlook (Revenue, USD Million, 2012 – 2025)

  • Neurosurgery and Spine Surgery
  • ENT Surgery
  • Dentistry
  • Oncology
  • Gynecology
  • Urology
  • Ophthalmology
  • Plastic & Reconstructive Surgeries
  • Other Surgeries

U.S. Surgical Microscopes Regional Outlook (Revenue, USD Million, 2012 – 2025)

  • U.S.
    • California
    • Texas
    • Ohio
    • Pennsylvania
    • New York
    • Massachusetts
    • Illinois
    • Florida
    • New Jersey
    • Michigan
    • Rest of U.S.

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/us-surgical-microscopes-market-analysis                                                                                                                                                             

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Contrast Media Agent Market Will Reach $5.96 Billion By 2025: Grand View Research, Inc.

 

The global contrast media agents market size is estimated to reach USD 5.96 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.8% during the forecast period. Increasing burden of chronic diseases is augmenting diagnostic imaging procedure volumes, which is providing a fillip to the market.

Competitive strategies, such as acquisitions and indication extensions for existent products, adopted by players are expected to trigger the growth of the market. The companies stirring changes in the space is restricted to few in number. Among these, Guerbet, GE Healthcare, and Bayer were the forerunners with top-selling drugs in their respective portfolios and commanding more than 40% share in 2016. Bayer holds a prominent position in the arena owing to its leading MRI agent, Gadavist/Gadovist, a macrocyclic gadolinium agent. Guerbet is giving a stiff competition to its contemporaries since it has joined forces with Mallinckrodt. The acquisition has led to a streamlined portfolio of MRI and x-ray/CT contrast materials, which now hold center position in this space. GE competes with Omnipaque and Visipaque as a part of its suite of offerings, which account for nearly 12.0% market share.

us-contrast-media-agents-market

Along with increasing incidence of chronic diseases, rising demand and use of diagnostic imaging modalities is driven by advancements in the underlying technologies. Equipment advancements include innovation such as syringeless injectors, which help in achieving greater accuracy in dose delivery, shorter examination time, and higher patient throughput.

Regionally, North America will continue to dominate the contrast media agents market throughout the forecast period. Presence of well-established healthcare infrastructure, availability of advanced technologies as well as recent launch of new contrast media agents for specific indications are contributing to the growth of the region.

Browse full research report on Contrast Media Agent Market: www.grandviewresearch.com/industry-analysis/contrast-media-contrast-agents-market                             

Further key findings from the study suggest:                     

  • In 2016, iodinated contrast agents registered the highest sales in the market due to high penetration of contrast media agents in x-ray and CT procedures, driven by availability of non-ionic stable iodinated agents for improved diagnosis
  • X-ray/CT modality technique led the market in terms of revenue in 2016 due to its wide acceptance and utilization in the market
  • Gastrointestinal applications are anticipated to register the fastest growth over the forecast period due to regulatory approval of new products in the U.S. market. For instance, Tagitol V was recently approved by the U.S. FDA for use in adult patients undergoing CTC procedures
  • On the regional front, North America captured the highest revenue in 2016 owing to presence of well-established healthcare infrastructure and availability of advanced technologies
  • Europe was the second largest segment in 2016, attributable to increasing usage of diagnostic imaging modalities such as MRI, CT, and ultrasound in the region
  • Key players in this space are Bayer AG, GE Healthcare, Guerbet, Lantheus Medical Imaging, and Bracco Diagnostics
  • Most of the key players are focusing on entering untapped regions and expanding their product portfolios through mergers and acquisitions.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare                                                                                                                                                                   Grand View Research has segmented the global contrast media agents market on the basis of agent type, modality, application, and region:

Contrast Media Agents Type Outlook (Revenue, USD Billion, 2016 – 2025)

  • Iodinated contrast media
  • Barium-based contrast media
  • Gadolinium-based contrast media
  • Microbubble contrast media

Contrast Media Agents Modality Outlook (Revenue, USD Billion, 2016 – 2025)

  • X-ray/CT contrast agents
  • MRI contrast agents
  • Ultrasound contrast agents

Contrast Media Agents Application Outlook (Revenue, USD Billion, 2016 – 2025)

  • Cardiovascular disorders
  • Neurological disorders
  • Gastrointestinal disorders
  • Cancer
  • Nephrological disorders
  • Musculoskeletal disorders
  • Others

Contrast Media Agents Regional Outlook (Revenue, USD Billion, 2016 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • France
  • Asia
    • Japan
    • India
  • Row

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-contrast-media-contrast-agents-market                                

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Reprocessed Medical Devices Market Will Reach $5 Billion By 2022: Grand View Research, Inc.

 

The global reprocessed medical devices market is expected to reach USD 5.0 billion by 2022, according to a new study by Grand View Research, Inc. The increasing generation of medical waste coupled with the lack of centralized support for waste disposal in the healthcare industry is expected to drive the demand for reprocessed medical devices market. Additionally, the long-term cost-efficiency associated with these devices as compared to that of the original device is the high impact rendering driver of the industry.

According to the Association of Medical Device Reprocessors (AMDR),hospitals witness up to 50% cost saving on every purchase of the reprocessed medical device, thereby spending only a limited amount, on waste disposal.

Consequentially, reprocessing has also facilitated reduction in device cost by the original equipment manufacturer in a vain to compete with the third-party reprocessors, thus exerting a positive cumulative effect on the industry growth.

Furthermore, the continuous deterioration of environmental conditions as a consequence of increasing landfills is anticipated to induce the demand for reprocessed medical devices. Reprocessing allows hospitals to divert over 8,000 pounds of Regulated Medical Waste (RMW) from landfills every year, thereby propelling the demand for the reprocessed medical devices market.

The rising initiatives by organizations, such as Association of periOperative Registered Nurses, American Nursing Association, and Practice Greenhealth, in collaboration with governmental and intergovernmental agencies, pertinent to increasing awareness with respect to medical device reprocessing is further expected to provide lucrative growth platform to this industry in near future.

Browse full research report on Reprocessed Medical Devices Market: www.grandviewresearch.com/industry-analysis/reprocessed-medical-devices-market         

Further key findings from the study suggest:                     

  • Cardiovascular devices dominated the product segment of the overall reprocessed medical devices market in terms of revenue share at over 55.0% in 2014,owing to a wide range of these devices approved by the U.S. FDA for diagnostics and therapeutics applications
  • Diagnostic electrophysiology catheters constituted the largest share at over 24.0% of the cardiovascular sub-segment in 2014 and positioning devices are expected to be the fastest growing at market over the forecast period. This can be attributed to the third-party processors involved in the reprocessing of single-use catheters due to high-cost savings
  • Hospitals held a substantial share of the end-use segment and constituted for over 40.0% of the overall market owing to increased in-house and third-party reprocessing due to the massive waste produced through resource users. The aforementioned provides lucrative opportunities for hospitals to contain the expenditure
  • As of 2014, North America dominated the overall reprocessed medical device market at over 47.0%owing to the presence of a large number of non-profit organizations, governmental, intergovernmental agencies, hospitals, donor agencies, and medical product manufacturers involved in reprocessing activities
  • Asia Pacific is anticipated to be the fastest growing regional market over the forecast period due to the presence of untapped opportunities in the emerging economies and rising investments in the healthcare infrastructure by global market players. This is predicted to impel growth in Asia Pacific
  • The key players in this industry are adopting collaborative strategies with public and private institutions and product approvals for business and geographical expansion. For instance, in January 2016,Centurion Medical Products Corporation acquired Nuvo-Med, Inc., a manufacturer of DisImpactor class I medical devices used for the treatment of fecal impaction in a probe to business expansion

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                         

Grand View Research has segmented the reprocessed medical devices market on the basis of product, end-use, and region:

Global reprocessed medical devices product outlook (Revenue, USD Million, 2012 – 2022)

  • Cardiovascular
    • Blood Pressure Cuffs
    • Positioning Devices
    • Cardiac Stabilization Devices
    • Diagnostic Electrophysiology Catheters
    • Electrophysiology Cables
    • Deep Vein Thrombosis Compression Sleeves
  • Laparoscopic
    • Harmonic Scalpels
    • Endoscopic Trocars
  • Gastroenterology
    • Biopsy Forceps
    • Others
  • General Surgery Devices
    • Balloon Inflation Devices
    • Pressure Bags
  • Orthopedic Devices

Global reprocessed medical devices end-use outlook (Revenue, USD Million, 2012 – 2022)

  • Hospitals
  • Home Healthcare
  • Others

Reprocessed medical devices regional outlook (Revenue, USD Million, 2012 – 2022)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-reprocessed-medical-devices-market                                        

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Ventricular Assist Device Market Will Be Worth $1.98 Billion By 2022: Grand View Research, Inc.

 

The global ventricular assist device market is expected to reach USD 1.97 billion by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to its rapid growth include rising prevalence of cardiovascular disorders coupled with the development of technological advanced products such as miniature device with infection reduction technology.

Furthermore, increasing healthcare expenditure, favorable reimbursement policies and advanced technological facilities, are expected to positively reinforce ventricular assist device market growth over the next seven years.

Ventricular assist device market is segmented on the basis of type of product which includes left ventricular, right ventricular and bi-ventricular assist device. Key factors attributing to rapidly increasing number of patients with end stage heart failure and low availability of therapeutic options are among the key factors attributing to the market growth.

With continual shortage of organ donors and increasing demand of LVADs’ for bridge to transplantation in patients suffering from end stage heart failure, is expected to positively reinforce market growth over the forecast period.

ventricular-assist-devices-market.png
U.S. ventricular assist device market, by product, 2012 – 2022 (USD Million)

Lack of developed reimbursement policies in underdeveloped economies of Africa and Asia is one of the key factors attributing for low penetration of these device. However, constant economic development, improving healthcare infrastructure and reimbursement policies in countries such as India and China is expected to positively reinforce market growth in next seven years.

Technological advancements in VADs have been a continuous process since the launch of first generation device. First generation VADs are referred to as pulsatile volume displacement pumps which are powered by pneumatic or electrical drive systems. Some of the U.S. FDA approved products are the Abiomed BVS5000, Worldheart Novacor System (LVAS).

Second generation ventricular assist device which are usually known as continuous flow LVADs were developed to overcome several limitations of the pulsatile displacement systems. At present, second generation LVADs that are available include the TandemHeart pVAD, Thoratec Heartmate II, Jarvik 2000, and the Impella Pump System.

Third generation ventricular assist device such as VentrAssist, DuraHeart, HeartMate III LVAD and others are currently under various stages of development, clinical trials and commercialization stages. These third generation ventricular assist device are continuous flow device with more advancement in product design, materials, battery capacity and size. Constant development in these devices serves as a high impact rendering driver for the growth of the market.

Browse full research report on Ventricular Assist Device Market: www.grandviewresearch.com/industry-analysis/ventricular-assist-devices-market   

Further key findings from the study suggest:                     

  • In 2014, North America accounted for largest market share of over55%. Key factors attributing to its large share include presence of advanced healthcare infrastructure, and high level of collaboration between various stakeholders including medical fraternity, medical device industry, regulatory authorities, universities and others.
  • Furthermore, presence of high research expenditure by public and private entities in healthcare sector is anticipated to propel market growth for ventricular assist device in the coming seven years.
  • Asia Pacific is expected to be one of the fastest growing markets, growing at a CAGR of over17% during the forecast period. Key factors attributed to the growth are high economic growth in countries such as China, Brazil, India, and South Korea coupled with high unmet medical needs is expected to boost usage rates of ventricular assist device.
  • Key players operating in ventricular assist device market include Abiomed, HeartWare International, Thoratec, Inc., Berlin Heart, Cardiac Assist and ReliantHeart

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                                     

Grand View Research has segmented the ventricular assist device market on the basis of product and region:

Ventricular Assist device Product Outlook (Revenue, USD Million, 2014 – 2022)

  • Left ventricular assist device
  • Right ventricular assist device
  • Bi-ventricular assist device

Ventricular Assist device Regional Outlook (Revenue, USD Million, 2014 – 2022)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-ventricular-assist-devices-market                                                                                                                             

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Medical Device Testing Services Market Will Be Worth $13.4 Billion By 2025: Grand View Research, Inc.

 

The global medical device testing services market size is expected to reach USD 13.4 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 11.5% during the forecast period. Increasing spending in preclinical phase of medical devices coupled with growing outsourcing rate is anticipated to help the market gain significant traction.

Surging demand for in-vitro test is also projected to fuel demand for testing services as many CROs are developing novel in-vitro methods to replace traditional in-vivo methods, which require animal testing. Improvements in procedures for development and standardization of novel in vitro test methods, particularly for sensitization, cytotoxicity, and irritation, are also working in favor of the market.

us-medical-device-testing-services-market.png

There has been a significant increase in preclinical spending for both pharmaceutical and medical devices. This trend is estimated to contribute to the demand for testing services by medical device companies.

Stringent regulatory standards pertaining to user safety are supporting growing trend of outsourcing medical device testing services. Increasing demand for good quality products is poised to further trigger the demand for testing services by medical device companies. These companies are constantly trying to comply with stringent regulatory norms put forth by authorities across the globe.

A significant consolidation in the CRO space has been observed in recent years. For instance, in October 2017, Sterigenics International LLC acquired Toxikon Europe N.V., the European division of Toxikon Corporation, to strengthen its preclinical service portfolio for pharmaceutical and medical device companies.

Browse full research report on Medical Device Testing Services Market : www.grandviewresearch.com/industry-analysis/medical-device-testing-services-market   

Further key findings from the study suggest:                     

  • The global biocompatibility testing market is anticipated to reach USD 4.1 billion by 2025, at a CAGR of 11.3% from 2017 to 2025
  • In terms of service, the chemistry test segment is likely to show the fastest growth during the forecast period
  • In terms of development phase, preclinical testing held the largest market share in 2016. The segment will continue to dominate the market throughout the forecast period, accounting for about two third of the overall revenue by 2025.
  • Asia Pacific is expected to dominate the medical device testing service market during the forecast period. The regional market will post a CAGR of over 12.0% during the same period. Europe and North America held remarkable cumulative share in 2016 owing to well established manufacturing infrastructure for high end and complex medical devices
  • The market is partially consolidated and competitive in nature. Some of the key companies present in the market are Toxikon, Inc.; SGS SA; Eurofins Scientific, LLC; Intertek Group plc; WuXi AppTec, Pace Analytical Services, NORTH AMERICAN SCIENCE ASSOCIATES INC.; Sterigenics International LLC; Charles River Laboratories International Inc.; American Preclinical Services; and Medical Device Testing Services.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                                

Grand View Research has segmented the global medical device testing services market report on the basis of service, phase, and region:

Medical Device Testing Services Service Outlook (Revenue, USD Million, 2014 – 2025)

  • Biocompatibility Tests
  • Chemistry Test
  • Microbiology & Sterility Testing
    • Bioburden Determination
    • Pyrogen & Endotoxin testing
    • Sterility Test & Validation
    • Antimicrobial Activity Testing
  • Package Validation

Medical Device Testing Services Phase Outlook (Revenue, USD Million, 2014 – 2025)

  • Preclinical
  • Clinical

Medical Device Testing Services Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-medical-device-testing-services-market                                                                                                                            

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Sleep Apnea Devices Market Is Anticipated To Surpass $7.9 Billion By 2022: Grand View Research, Inc.

 

Global sleep apnea devices market is expected to reach over USD 7,991.2 Million by 2022 according to a new report by Grand View Research Inc. Technological advancements pertaining to the development of novel PAP devices and PAP masks which are portable, highly efficient and are easy to use is expected to positively reinforce market growth.

The U.S. has one of the highest numbers of people suffering from sleep apnea. In 2014, as per the National Sleep Foundation, more than 18 million adults across different age groups have sleep apnea and nearly two to three percent cases are related to childhood OSA and the numbers are much higher in children with habitual snoring. The increasing prevalence of sleep apnea in co-morbidities and subsequent increase in the diagnosis and treatment rate is a major factor expected to boost the product sales over the next seven years.

us-sleep-apnea-devices-market.png

The most common conditions associated with this disorder include respiratory diseases, stroke, atrial fibrillation, coronary artery disease, congestive heart failure, hypertension, obesity and type II diabetes. The conditions such as COPD, asthma, and other respiratory disorders are significantly contributing to the growth in the number of obstructive sleep apnea (OSA) cases. Key reasons attributing to the aforementioned medical condition include obesity, rising air pollution levels, and life style factors such as smoking, substance abuse and lack of early stage diagnosis. As per data published by theAmerican Thoracic Society (ATS), nearly 50% of the patients reported a significant disturbance in sleep quality and quality of life. The patients suffering from COPD are reported to have the higher chances of daytime sleepiness, insomnia and nightmares compared to the general population.

The sleep apnea devices market is expected to increase at a rapid pace over the forecast period an account of high prevalence of sleep apnea in geriatric population coupled with increasing instances of sleep apnea in co-morbidities.

On the basis of product, the market is segmented as therapeutics and diagnostics devices. In terms of revenues, the therapeutics segment accounted for the maximum share of over 47% and in terms of volumes, this segment accounted for over 63% respectively. The therapeutics devices segment is expected to continue its strong growth with a CAGR of 9.2% for revenues and a CAGR of 10.7% for volumes over the forecast period.

Furthermore, the rise in demand for CPAP, BiPAP, APAP devices, oral appliances and CPAP masks such as the full face masks, nasal masks, and other products is expected to provide lucrative opportunities for the market expansion over the forecast period.

Browse full research report on Sleep Apnea Devices Market: www.grandviewresearch.com/industry-analysis/sleep-apnea-devices-market  

Further key findings from the study suggest:                     

  • In 2014, North America dominated the sleep apnea devices market with the maximum volume share of 37%. The presence of advanced healthcare infrastructure, reimbursement structure, high prevalence and treatment rates for sleep disorders and COPD and the significant rise in geriatric population are amongst the key reasons for the high share.
  • The Asia pacific sleep apnea devices market is expected to be the fastest growing region with a CAGR of 10.9% in terms volume for the next seven years. Rising geriatric population, high target disease prevalence rates, deteriorating life style and sleep patterns are expected to act as high impact drivers for the market growth in this region. Moreover, increasing awareness about sleep disorders and the establishment of several sleep testing labs and service centers is expected to boost the usage rates over the forecast period.
  • Key market players include ResMed, Phillips Healthcare, ImThera Medical Inc., Invacare Corporation, BMC Medical Co.Ltd., Compumedics Limited, GE Healthcare, Braebon Medical Corporation, Fisher & Paykel Healthcare, Nihon Kohden, Cadwell Laboratories, and Curative Medical Inc.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                             

Grand View Research has segmented the Sleep Apnea Devices market on the basis of product, technology, application, test location, and region:

Sleep Apnea Devices Market Product Outlook, by Revenue (USD Million, 2015 – 2022)

  • Sleep Apnea Therapeutic Devices
  • Diagnostic Devices

Sleep Apnea Therapeutic Devices Market Outlook, by Revenue (USD Million, 2015 – 2022)

  • Airway Clearance Systems
  • Adaptive Servo-Ventilation Systems
  • Positive Airway Pressure (PAP) device
  • Oral Appliances
  • Oxygen Devices
  • Other Devices

Sleep Apnea Positive Airway Pressure Devices Market Outlook, by Revenue (USD Million, 2015 – 2022)

  • Bilevel Positive Airway Pressure (BiPAP)
  • Continuous Positive Airway Pressure (CPAP)
  • Automatic Positive Airway Pressure (APAP) device

Sleep Apnea Other Devices Market Outlook, by Revenue (USD Million, 2015 – 2022)

  • Masks
  • Tubes
  • Humidifiers
  • Filters

Sleep Apnea Masks Market Outlook, by Revenue (USD Million, 2015 – 2022)

  • Full Face Masks
  • Nasal Masks
  • Nasal Pillows
  • Nasal Prongs
  • Oral Masks

Sleep Apnea Diagnostic Devices Market Outlook, by Revenue (USD Million, 2015 – 2022)

  • Actigraphy Systems
  • Polysomnography (PSG) device
  • Respiratory polygraphs
  • Single-channel screening devices pulse oximeters

Sleep Apnea Market Volume, by Product, 2012 – 2020 (000’units)

  • Sleep ApneaTherapeutic Devices
  • Diagnostic Devices

Sleep Apnea TherapeuticDevicesMarket Volume, by Product, 2012 – 2020 (000’units)

  • Airway Clearance Systems
  • Adaptive Servo-Ventilation Systems
  • Positive Airway Pressure (PAP) device
  • Oral Appliances
  • Oxygen Devices
  • Other Devices

Sleep Apnea Positive Airway Pressure (PAP) deviceMarket Volume, by Product, 2012 – 2020 (000’units)

  • Bilevel Positive Airway Pressure (BiPAP)
  • Continuous Positive Airway Pressure (CPAP)
  • Automatic Positive Airway Pressure (APAP) device

Sleep Apnea Other Devices Market Outlook, by Product, 2012 – 2020 (000’units)

  • Masks
  • Tubes
  • Humidifiers
  • Filters

Sleep Apnea Masks Market Volume, by Product, 2012 – 2020 (000’units)

  • Full Face Masks
  • Nasal Masks
  • Nasal Pillows
  • Nasal Prongs
  • Oral Masks

Sleep Apnea Diagnostics Sleep Apnea Devices Market Volume, by Product, 2012 – 2020 (000’units)

  • Actigraphy Systems
  • Polysomnography (PSG) device
  • Respiratory polygraphs
  • Single-channel screening devices pulse oximeters

Sleep Apnea Therapeutics Sleep Apnea Devices Market ASP, by Product, 2012 – 2020 (USD/Unit)

  • Airway Clearance Systems
  • Adaptive Servo-Ventilation Systems
  • Positive Airway Pressure (PAP) device
  • Oral Appliances
  • Oxygen Devices
  • Other Devices

Sleep Apnea Other Sleep Apnea Devices Market ASP, by Product, 2012 – 2020 (USD/Unit)

  • Bilevel Positive Airway Pressure (BiPAP)
  • Continuous Positive Airway Pressure (CPAP)
  • Automatic Positive Airway Pressure (APAP) device

Sleep Apnea Other Devices Market ASP, by Product, 2012 – 2020 (USD/Unit

  • Masks
  • Tubes
  • Humidifiers
  • Filters

Sleep Apnea Masks Market ASP, by Product, 2012 – 2020 (USD/Unit)

  • Full Face Masks
  • Nasal Masks
  • Nasal Pillows
  • Nasal Prongs
  • Oral Masks

Sleep Apnea Diagnostics Sleep Apnea Devices Market ASP, by product, 2012 – 2020 (USD/Unit)

  • Actigraphy Systems
  • Polysomnography (PSG) device
  • Respiratory polygraphs
  • Single-channel screening devices pulse oximeters

Sleep Apnea Devices Market Regional Outlook, by Revenue (USD Million, 2015 – 2022)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • RoW
    • Brazil

Sleep Apnea Devices Market Regional Outlook, by Volume, by Product, 2012 – 2020 (000’units)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • RoW
    • Brazil

Sleep Apnea Therapeutics Sleep Apnea Devices Regional Outlook, by Market ASP, by Product, 2012 – 2020 (USD/Unit)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • RoW
    • Brazil

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-sleep-apnea-devices-market                                                      

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com